The effects of antiviral agents on serum hepatitis B e antigen levels in chronic type B hepatitis
- 1 April 1988
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 3 (2) , 143-152
- https://doi.org/10.1111/j.1440-1746.1988.tb00230.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Changes of serum aminotransferase activities in relation to serum hepatitis Be antigen levels in chronic type B hepatitisJournal of Gastroenterology and Hepatology, 1987
- Acute Dane Particle Suppression with Recombinant Leukocyte A Interferon in Chronic Hepatitis B Virus InfectionThe Journal of Infectious Diseases, 1983
- Adenine Arabinoside 5′–Monophosphate Treatment of Chronic Type B HepatitisHepatology, 1982
- Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).Gut, 1982
- Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infectionJAMA, 1982
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular CarcinomaNew England Journal of Medicine, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.BMJ, 1978
- Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon.Gut, 1978
- ADMINISTRATION OF HUMAN FIBROBLAST INTERFERON IN CHRONIC HEPATITIS-B INFECTIONThe Lancet, 1976